Nathaniel Weygant

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Cancers

Journal of oncology

Molecular cancer research : MCR

Expert opinion on therapeutic targets

Fujian University of Traditional Chinese Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fujian University of Traditional Chinese Medicine Sep 10 2019

China

Professor and PhD Supervisor :: Integrative Medicine

Publications

Ling Ding, Yuning Yang, Qin Lu, Dongfeng Qu, Parthasarathy Chandrakesan, Hailan Feng, Hong Chen, Xuzheng Chen, Zhuhui Liao, Jian Du, Zhiyun Cao, Nathaniel Weygant
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis. International journal of molecular sciences 23 (21) (2022)
Ling Ding, Yuning Yang, Yang Ge, Qin Lu, Zixing Yan, Xuzheng Chen, Jian Du, Sassan Hafizi, Xiaohui Xu, Jiannan Yao, Jian Liu, Zhiyun Cao, Nathaniel Weygant
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity. Cancers 13 (22) (2021)
Yang Ge, Xiaona Fan, Xuying Huang, Nathaniel Weygant, Zeru Xiao, Rui Yan, Heshu Liu, Jian Liu, Guangyu An, Jiannan Yao
DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway. Molecular cancer research : MCR 19 (12) (2021)
Yuning Yang, Ling Ding, Zhiyun Cao, Dongfeng Qu, Nathaniel Weygant
Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer? Expert opinion on therapeutic targets 24 (12) (2020)
Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, Courtney W Houchen, Jun Peng, Dongfeng Qu
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment. Cancers 12 (12) (2020)
Parthasarathy Chandrakesan, Janani Panneerselvam, Randal May, Nathaniel Weygant, Dongfeng Qu, William L Berry, Kamille Pitts, Ben Z Stanger, Chinthalapally V Rao, Michael S Bronze, Courtney W Houchen
DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization. Molecular cancer therapeutics 19 (7) (2020)
Yang Ge, C Benedikt Westphalen, Wen Wee Ma, Kenneth J Vega, Nathaniel Weygant
Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers. Journal of oncology 2019 (2019)
Nathaniel Weygant, Yang Ge, C Benedikt Westphalen, Wen Wee Ma, Kenneth J Vega
Role of the Microenvironment in Gastrointestinal Tumors. Journal of oncology 2019 (2019)
Yang Ge, Nathaniel Weygant, Dongfeng Qu, Randal May, William L Berry, Jiannan Yao, Parthasarathy Chandrakesan, Wei Zheng, Lichao Zhao, Karena L Zhao, Michael Drake, Kenneth J Vega, Michael S Bronze, James J Tomasek, Guangyu An, Courtney W Houchen
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. International journal of cancer 143 (5) (2018)

Nathaniel Weygant.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nathaniel Weygant